Reinforcing and neural activating effects of norharmane, a non-nicotine tobacco constituent, alone and in combination with nicotine

Neuropharmacology

Volumn 85, Issue , 2014, Pages 293-304

  Arnold, Monica M ^a,b   Loughlin, Sandra E ^a   Belluzzi, James D ^a   Leslie, Frances M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

cfos; Monoamine oxidase; Nicotine; Norharmane; Self administration; Tobacco

Indexed keywords

BETA CARBOLINE; MESSENGER RNA; NICOTINE; PROTEIN C FOS; HARMINE; MONOAMINE OXIDASE INHIBITOR; NICOTINIC AGENT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETERIZATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SELF ADMINISTRATION; ENZYME METABOLISM; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REINFORCEMENT; TOBACCO DEPENDENCE; TREATMENT DURATION; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN; DRUG EFFECTS; DRUG POTENTIATION; DRUG SEEKING BEHAVIOR; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; DRUG SYNERGISM; DRUG-SEEKING BEHAVIOR; HARMINE; MALE; MONOAMINE OXIDASE INHIBITORS; NICOTINE; NICOTINIC AGONISTS; PROTO-ONCOGENE PROTEINS C-FOS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); RNA, MESSENGER; SELF ADMINISTRATION;

EID: 84903162020     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.05.035     Document Type: Article

References (54)

1. S.S. Baum, R. Hill, and H. Rommelspacher Norharman-induced changes of extracellular concentrations of dopamine in the nucleus accumbens of rats Life Sci. 56 1995 1715 1720
2. J.D. Belluzzi, R. Wang, and F.M. Leslie Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats Neuropsychopharmacology 30 4 2005 705 712 (Pubitemid 40397076)
3. N. Benowitz Neurobiology of nicotine addiction: implications for smoking cessation treatment Am. J. Med. 121 4A 2008 S3 S10
4. I. Berlin, and R. Anthenelli Monoamine oxidases and tobacco smoking Int. J. Neuropsychopharmacol. 4 1 2001 33 42 (Pubitemid 32390633)
5. R.S. Broide, R.T. Robertson, and F.M. Leslie Regulation of alpha7 nicotinic acetylcholine receptors in the developing rat somatosensory cortex by thalamocortical afferents J. Neurosci. 16 9 1996 2956 2971 (Pubitemid 26121839)
6. A.R. Caggiula, E.C. Donny, M.I. Palmatier, X. Liu, N. Chaudhri, and A.F. Sved Chapter 6: the role of nicotine in smoking: a dual-reinforcement model Nebr. Symp. Motiv. 55 2009 91 109
7. R.N. Cardinal, J.A. Parkinson, J. Hall, and B.J. Everitt Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex Neurosci. Biobehav. Rev. 26 3 2002 321 352 (Pubitemid 34555410)
8. D. Cechetto, and C.B. Saper Evidence for a viscerotopic sensory representation in the cortex and thalamus of the rat J. Comp. Neurol. 262 1987 27 45 (Pubitemid 17106944)
9. K.J. Clemens, S. Caillé, and M. Cador The effects of response operandum and prior food training on intravenous nicotine self-administration in rats Psychopharmacology (Berl) 211 2010 43 54
10. M.R. Costello, D.D. Reynaga, C.Y. Mojica, N.T. Zaveri, J.D. Belluzzi, and F.M. Leslie Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats Neuropsychopharmacology 2014 1 9 Epub ahead of print
11. G. Di Chiara, and A. Imperato Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc. Natl. Acad. Sci. 85 1988 5274 5278
12. M. Dragunow, and R. Faull The use of c-fos as a metabolic marker in neuronal pathway tracing J. Neurosci. Methods 29 3 1989 261 265 (Pubitemid 19222725)
13. R.A. Fisher Statistical Methods for Research Workers 13th ed. 1958 Oliver & Boyd Edinburgh
14. J.S. Fowler, J. Logan, G.-J. Wang, and N.D. Volkow Monoamine oxidase and cigarette smoking NeuroToxicology 24 1 2003 75 82 (Pubitemid 36091163)
15. M. Gallagher, R. McMahan, and G. Schoenbaum Orbitofrontal cortex and representation of incentive value in associative learning J. Neurosci. 19 15 1999 6610 6614 (Pubitemid 29347459)
16. F. Georges, and G. Aston-Jones Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons J. Neurosci. 22 12 2002 5173 5187 (Pubitemid 37465630)
17. K. Gothard, W. Skaggs, K. Moore, and B. McNaughton Binding of hippocampal CA1 neural activity to multiple reference frames in a landmark-based navigation task J. Neurosci. 16 2 1996 823 835 (Pubitemid 26028838)
18. K. Guillem, C. Vouillac, M. Azar, L. Parsons, G. Koob, and M. Cador et al. Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats J. Neurosci. 25 38 2005 8593 8600 (Pubitemid 41362035)
19. K. Guillem, C. Vouillac, M. Azar, L. Parsons, G. Koob, and M. Cador et al. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats Eur. J. Neurosci. 24 12 2006 3532 3540 (Pubitemid 44952618)
20. B.J. Hall, C. Wells, C. Allenby, M.Y. Lin, I. Hao, L. Marshall, J.E. Rose, and E.D. Levin Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats Pharmacol. Biochem. Behav. 120 2014 103 108
21. T. Herraiz, and C. Chaparro Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors Biochem. Biophysical Res. Commun. 326 2 2005 378 386 (Pubitemid 39593558)
22. N.M. Holmes, A.R. Marchand, and E. Courtureau Pavlovian to instrumental transfer: a neurobehavioral perspective Neurosci. Biobehav. Rev. 34 2010 1277 1295
23. D. Jorenby, J. Hays, N. Rigotti, S. Azoulay, E. Watsky, and K.E. Williams et al. Efficacy of varenicline, an alpha-4 beta-2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA 296 1 2006 56 63
24. P.W. Kalivas, and M. Nakamura Neural systems for behavioral activation and reward Curr. Opin. Neurobiol. 9 2 1999 223 227 (Pubitemid 29201796)
25. K.J. Kovács C-fos as a transcription factor: a stressful (re)view from a functional map Neurochem. Int. 33 4 1998 287 297 (Pubitemid 28529506)
26. J. LeDoux The emotional brain, fear, and the amygdala Cell. Mol. Neurobiol. 23 4 2003 727 738
27. A. Lewis, J. Miller, and R. Lea Monoamine oxidase and tobacco dependence Neurotoxicology 28 1 2007 182 195 (Pubitemid 46187252)
28. S. Lotfipour, M.M. Arnold, D. Hogenkamp, K. Gee, J.D. Belluzzi, and F.M. Leslie The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition Neuropharmacology 61 2011 95 104
29. A. Manzardo, L. Stein, and J.D. Belluzzi Rats prefer cocaine over nicotine in a two-lever self-administration choice test Brain Res. 924 2002 10 19 (Pubitemid 34017459)
30. W.D. Myers, K.T. Ng, and G. Singer Intravenous self-administration of acetaldeyde in the rat as a function of schedule, food deprivation and photoperiod Pharmacol. Biochem. Behav. 17 1982 807 811 (Pubitemid 13208442)
31. S. Pagliusi, M. Tessari, S. DeVevey, C. Chiamulera, and E. Pich The reinforcing properties of nicotine are associated with a specific patterning of c-fos expression in the rat brain Eur. J. Neurosci. 8 11 1996 2247 2256 (Pubitemid 26387886)
32. J. Peters, P.W. Kalivas, and G.J. Quirk Extinction circuits for fear and addiction overlap in prefrontal cortex Learn. Mem. 16 2009 279 288
33. M. Pich, S. Pagliusi, M. Tessari, D. Talabot-Ayer, R. Hooft van Huijsduijnen, and C. Chiamulera Common neural substrates for the addictive properties of nicotine and cocaine Science 275 5296 1997 83 86 (Pubitemid 27020313)
34. E. Poindexter Jr., and R. Carpenter The isolation of harmane and norharmane from tobacco and cigarette smoke Phytochemistry 1 1962 215 221
35. R. Polosa, and N.L. Benowitz Treatment of nicotine addiction: present therapeutic options and pipeline developments Trends Pharmacol. Sci. 32 5 2011 281 289
36. V. Reus, and B. Smith Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines Int. J. Clin. Pract 62 11 2008 1753 1768
37. J.M. Richards, R.C. Plate, and M. Ernst Neural systems underlying motivated behavior in adolescence: implications for preventative medicine Prev. Med. 55 1 2012 S7 S16
38. N.R. Richardson, and D.C.S. Roberts Progressive ratio schedules in drug reinforcement studies in rats: a method to evaluate reinforcing efficacy J. Neurosci. Methods 66 1996 1996 1 11 (Pubitemid 26180064)
39. H. Rommelspacher, M. Meier-Henco, and M. Smolka The levels of norharman are high enough after smoking to affect monoamine oxidase B in platelets Eur. J. Pharmacol. 441 2002 115 125 (Pubitemid 34465697)
40. J. Rose, A. Salley, F.M. Behm, J.E. Bates, and E.C. Westman Reinforcing effects of nicotine and non-nicotine components of cigarette smoke Psychopharmacology 210 2010 1 12
41. S. Rossignol, R. Dubuc, and J.-P. Gossard Dynamic sensorimotor interactions in locomotion Physiol. Rev. 86 1 2006 89 154
42. W. Schultz Multiple reward signals in the brain Nat. Rev. Neurosci. 1 3 2000 199 207
43. S.R. Sesack, and A.A. Grace Cortico-basal ganglia reward network: microcircuitry Neuropharmacology 35 1 2010 27 47
44. T. Sheehan, R. Chambers, and D. Russell Regulation of affect by the lateral septum: implications for neuropsychiatry Brain Res. Rev. 46 1 2004 71 117 (Pubitemid 39036164)
45. E. Tabuchi, A.A. Furusawa, E. Hori, K. Umeno, T. Ono, and H. Nishijo Neural correlates to action and rewards in the rat posterior cingulate cortex Neuroreport 16 9 2005 949 953 (Pubitemid 40904745)
46. U.S. Department of Health and Human Services The Health Consequences of Smoking: a Report of the Surgeon General 2004 U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
47. U.S. Department of Health and Human Services How Tobacco Smoke Causes Disease: the Biology and Behavioral Basis for Smoking-Attributable Disease. A Report of the Surgeon General 2010 U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
48. Y. Van der Werf, M. Witter, and H. Groenewegen The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness Brain Res. Rev. 39 2-3 2002 107 140 (Pubitemid 35341095)
49. A.-S. Villégier, L. Salomon, S. Granon, J.-P. Changeux, J.D. Belluzzi, F.M. Leslie, and J.-P. Tassin Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine Neuropsychopharmacology 31 8 2006 1704 1713 (Pubitemid 44106701)
50. A.-S. Villégier, S. Lotfipour, S. McQuown, J.D. Belluzzi, and F.M. Leslie Tranylcypromine enhancement of nicotine self-administration Neuropharmacology 52 2007 1415 1425 (Pubitemid 46601533)
51. A.-S. Villégier, J.D. Belluzzi, and F.M. Leslie Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self-administration Synapse 65 2011 479 489
52. D.L. Walker, D.J. Toufexis, and M. Davis Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety Eur. J. Pharmacol. 46 2003 199 216 (Pubitemid 36205081)
53. 2 adrenoreceptor subtype mRNAs in adult and developing rat brain Brain Res. Protoc. 3 1999 229 241 (Pubitemid 29023522)
54. G.Y. Zou Towards using confidence intervals to compare correlations Psychol. Methods 12 2007 399 413